This is one hot tech discussion!  Protein therapeutics have great potential, but significant limitations to their utility. Dr. Dan Mandell of GRO Biosciences explains how they are using a non-standard library of amino acids to increase protein presentation. Along with glycosylation and other modifications, the proteins are more therapeutically active, as such changes can improve issues like stability and visibility to the immune system. The technologies are being used to design therapeutic solutions for autoimmune diseases, such as myasthenia gravis. This is a technology dense episode that stretches the bounds of molecular biology.